Client of a consultant lobbyist
Canadian Association of Nuclear Medicine
- Meetings this Parliament
- 15
- With MPs
- 5
- Since Nov 2021
- 15
- Active registrations
- 1
Most recent reported meeting: Oct 22, 2026.
Lobbying by Canadian Association of Nuclear Medicine: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Yasir Naqvi Liberal 3
- Maggie Chi Liberal 1
- Mona Fortier Liberal 1
- David J. McGuinty Liberal 1
Institutions
- Health Canada (HC)7
- House of Commons6
- Finance Canada (FIN)3
- Natural Resources Canada (NRCan)2
- Global Affairs Canada (GAC)1
Registrations in effect
Consultant In effect since Oct 2, 2026
Consultant Tristan Downe Dewdney of Downe Dewdney Strategies Ltd.
Consultant lobbyists
- Tristan Downe Dewdney
Institutions they may lobby: Atomic Energy of Canada Limited (AECL), Canadian Institutes of Health Research (CIHR), Canadian Nuclear Safety Commission (CNSC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Natural Resources Canada (NRCan), Privy Council Office (PCO), Senate of Canada
What they're lobbying on (1)Hide details
- Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning.
Registration 955469-386951-3. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Tristan Downe Dewdney · Consultant
- Marie-Christine Demers · Senior Policy Advisor, Natural Resources Canada (NRCan)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Madeleine Bird · Manager, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Marie-Christine Demers · Senior Policy Advisor, Natural Resources Canada (NRCan)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Elodie Grenier · Assistante de programmes, Global Affairs Canada (GAC)
- Madeleine Bird · Manager, Health Canada (HC)
- Kate Trotter · Senior Policy Analyst, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- David J. McGuinty · Member of Parliament
- Mona Fortier · Member of Parliament
- Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Yasir Naqvi · Member of Parliament
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Yasir Naqvi · Member of Parliament
- Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Yasir Naqvi · Member of Parliament
- Elina Li · Chief of Staff, House of Commons
- Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Elina Li · Chief of Staff, House of Commons
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Maggie Chi · Member of Parliament
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Jade Mallette · Chief of Staff to the Minister, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
-
Reported by Tristan Downe Dewdney · Consultant
- Jade Mallette · Chief of Staff to the Minister, Health Canada (HC)
Improving patient care in Canada by advancing nuclear medicine diagnostics and therapies, enhancing workforce capacity, investing in related infrastructure and equipment, improving isotope supply, expanding patient access, and supporting Canadian research to inform policy and planning. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.